SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-018569
Filing Date
2021-03-08
Accepted
2021-03-08 16:38:06
Documents
1
Period of Report
2021-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3969
  Complete submission text file 0001209191-21-018569.txt   5386
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (206) 221-8112
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3175 HANOVER STREET PALO ALTO CA 94304
Business Address
Kosacz Barbara (Reporting) CIK: 0001763316 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 21722452